Understanding Specific IgE to Act d 1 vs. Act d 8 in Kiwi Hypersensitivity

Understanding Specific IgE to Act d 1 vs. Act d 8 in Kiwi Hypersensitivity

Written Date: 20 November 2026Next Review Date: 20 November 2027

Kiwi fruit allergy is one of the most clinically significant food hypersensitivities in the UK, yet the distinction between specific IgE to Act d 1 and Act d 8 remains poorly understood by many people seeking clarity about their reactions. Component-resolved allergy blood testing now makes it possible to identify which kiwi protein is driving an immune response — a distinction that can meaningfully inform how someone understands their sensitivity. This article explains the science behind kiwi-specific IgE testing, what each component may indicate, and who might benefit from requesting this level of diagnostic detail through a nurse-led screening clinic.

What Is Specific IgE Testing in the Context of Kiwi Allergy?

Specific IgE (sIgE) testing is a blood-based screening approach that measures the level of immunoglobulin E antibodies directed against particular allergen proteins. In the context of kiwi hypersensitivity, the two most clinically relevant components tested are Act d 1 (actinidin) and Act d 8 (a PR-10 protein homologous to Bet v 1, the major birch pollen allergen).

A positive specific IgE result to either component does not confirm an allergy diagnosis, but it may suggest that the immune system has developed sensitisation to that particular protein — a distinction that can help guide further clinical decisions.

Snippet Definition: Specific IgE to Act d 1 and Act d 8 refers to blood test markers used in component-resolved diagnostics for kiwi fruit sensitivity. Act d 1 is a cysteine protease linked to genuine kiwi allergy, while Act d 8 is a cross-reactive PR-10 protein associated with pollen-food allergy syndrome.

Act d 1 vs. Act d 8: What Makes These Components Different?

Understanding the biological difference between these two proteins is essential for interpreting test results accurately.

Act d 1 (Actinidin) — The Primary Kiwi Storage Protein

Act d 1 is a cysteine protease and the dominant allergen in green kiwi (Actinidia deliciosa). It is considered a stable, heat-resistant storage protein, meaning it is not broken down easily during digestion or food processing.

Sensitisation to Act d 1 may be associated with:

  • Reactions to both raw and cooked kiwi
  • More pronounced gastrointestinal or systemic responses
  • Higher likelihood of a persistent, primary kiwi sensitisation
  • Potential relevance across different kiwi varieties

Act d 8 (PR-10 Protein) — The Pollen Cross-Reactor

Act d 8 belongs to the pathogenesis-related protein family (PR-10) and shares structural similarity with Bet v 1, the major birch pollen allergen. This makes Act d 8 a classic driver of pollen-food allergy syndrome (PFAS), also known in the UK as oral allergy syndrome.

Sensitisation to Act d 8 may be associated with:

  • Mild oral symptoms such as tingling or itching of the mouth and lips
  • Reactions predominantly to raw kiwi (heat labile protein)
  • Co-sensitisation to birch pollen, hazel, alder, or related tree pollens
  • Cross-reactive sensitivity to other PR-10-rich foods such as apple, peach, and cherry

Practical Insight: Someone who develops itchy lips after eating raw kiwi but tolerates kiwi in a smoothie or cooked dessert may be responding to Act d 8 rather than Act d 1 — a nuance that only component-resolved blood testing can help clarify.

Comparison Table: Act d 1 vs. Act d 8 in Kiwi Hypersensitivity

FeatureAct d 1 (Actinidin)Act d 8 (PR-10)
Protein ClassCysteine protease (storage protein)Pathogenesis-related protein (PR-10)
Heat StabilityStable — survives cookingLabile — destroyed by heat
Associated Reaction PatternSystemic or persistent responsesMild oral / localised symptoms
Cross-reactivityLimited cross-reactivityBirch, hazel, alder pollen; apple, peach
Pollen LinkGenerally independentStrongly linked to birch pollen allergy
Testing UtilityIndicates primary kiwi sensitisationIndicates pollen-food syndrome
Kiwi Varieties AffectedGreen kiwi most commonlyMultiple, depending on cross-reactive burden

Who Might Consider Specific IgE Component Testing for Kiwi?

Component-resolved testing for kiwi allergens may be worth exploring if:

  • You have experienced oral tingling, lip swelling, or throat irritation after eating kiwi and are unsure of the cause
  • You have a known birch pollen allergy and are noticing reactions to certain fruits
  • You have had whole kiwi extract testing that came back borderline or inconclusive
  • You are trying to understand whether your sensitivity is likely to be primary kiwi allergy or pollen-related cross-reactivity
  • You want clarity before discussing your symptoms further with an appropriate healthcare professional

This level of testing is particularly relevant for people living in London and across the UK, where birch pollen seasons are well-documented and pollen-food allergy syndrome is frequently underidentified. Many individuals in busy urban areas may attribute their fruit-related symptoms to digestive sensitivity rather than recognising the potential immunological connection.

You can explore our allergy blood testing options to find out what component panels are available through our nurse-led screening service.

What Do the Results of Specific IgE Testing Mean?

Specific IgE results are typically reported in kilounits per litre (kU/L) and may be graded from Class 0 (no detectable sensitisation) to Class 6 (very high sensitisation). It is important to understand that:

  • A detectable sIgE level does not automatically mean clinical allergy — it indicates sensitisation, which may or may not translate into symptoms
  • A negative result does not entirely rule out a food reaction, as other mechanisms can be involved
  • Results should always be interpreted alongside a detailed clinical history by an appropriate healthcare professional

Our clinic provides testing and reporting only. We do not offer diagnosis, prescriptions, or treatment. Following your results, we encourage you to share findings with a suitable healthcare professional for clinical interpretation.

For further information on how allergy blood testing works, visit our blog for related educational content.

How Often Should Specific IgE Levels Be Retested?

There is no universally fixed retesting interval for specific IgE to kiwi components. However, retesting may be considered:

  • After 12–24 months if symptoms have changed significantly
  • If new cross-reactive symptoms have developed alongside existing sensitivities
  • When clinical context evolves — for example, if a child's sensitisation profile is being monitored over time
  • If a previous test was borderline or low-positive and you wish to reassess your status

Our nurse-led team can advise on appropriate testing intervals based on your personal screening history. Learn more about our food allergy and intolerance testing services.

Kiwi Allergy Testing in London: What You Should Know

London's diverse population and high birch pollen burden make kiwi hypersensitivity — and particularly pollen-food allergy syndrome — a common but frequently missed presentation. Many individuals in the capital seek private screening to gain faster clarity on their symptoms without waiting for NHS referral pathways, which can be lengthy.

A nurse-led private screening clinic offers a straightforward, appointment-based service where blood is taken and results are reported clearly. This is distinct from GP services, specialist clinics, or treatment centres — our role is to provide accurate, timely testing data that you can take to your chosen healthcare professional.

Practical Insight: If you live in London and regularly experience seasonal hay fever alongside unexplained reactions to fruits, component-resolved testing for Act d 8 (and related cross-reactive markers) may provide useful context for your healthcare discussions.

FAQ: Specific IgE to Act d 1 and Act d 8 in Kiwi Hypersensitivity

1. What is the difference between Act d 1 and Act d 8 specific IgE?

Act d 1 is a stable kiwi storage protein linked to primary kiwi sensitisation, while Act d 8 is a heat-labile PR-10 protein associated with cross-reactive pollen-food allergy syndrome. Testing for both provides a more detailed picture than whole kiwi extract testing alone.

2. Can a blood test confirm that I have a kiwi allergy?

Specific IgE blood testing can indicate sensitisation to kiwi proteins, but it cannot confirm clinical allergy on its own. Results should always be discussed with an appropriate healthcare professional who can assess your full clinical history.

3. Is Act d 8 linked to birch pollen allergy?

Yes. Act d 8 shares structural similarity with Bet v 1, the major birch pollen allergen. People with birch pollen sensitisation may develop cross-reactive responses to kiwi and other PR-10-rich foods as a result.

4. Why might I react to raw kiwi but not cooked kiwi?

If your sensitisation is primarily to Act d 8, this may explain the pattern. Act d 8 is heat-labile, meaning it is broken down during cooking. Act d 1, by contrast, is heat-stable and may cause reactions regardless of preparation method.

5. How is specific IgE testing for kiwi components carried out?

It is a simple blood test. A small sample is taken and analysed in a laboratory for the presence of IgE antibodies to specific kiwi proteins. Our nurse-led clinic offers this as part of our allergy screening services.

6. Do I need a GP referral to access kiwi allergy blood testing?

No referral is needed to access testing through our private nurse-led clinic. You can book directly and receive your results report, which you are welcome to share with your GP or another healthcare professional.

7. Is kiwi allergy common in the UK?

Kiwi allergy is increasingly recognised in the UK, particularly among individuals with existing tree pollen sensitisation. It is considered one of the more frequently reported fruit allergies in European populations.

8. What other kiwi allergen components exist beyond Act d 1 and Act d 8?

Other identified kiwi components include Act d 2 (thaumatin-like protein), Act d 5 (kiwellin), Act d 9 (profilin), and Act d 11 (major latex-fruit cross-reactive protein), among others. The clinical significance of each varies. Component-resolved testing panels may cover multiple markers depending on the laboratory.

9. Can children have specific IgE testing for kiwi components?

Yes. Blood-based specific IgE testing can be carried out in children. If you are seeking testing for a child, our clinic team can advise on what is appropriate. All results should be discussed with a paediatric-aware healthcare professional.

10. What should I do with my specific IgE test results?

Your results report can be shared with your GP, an NHS allergy service, or any appropriate healthcare professional for clinical interpretation. Our role is to provide accurate, clearly reported screening data to support your healthcare decisions.

Explore Related Testing at Our Clinic

If you are exploring allergy-related blood testing, you may also find the following helpful:

A Note on Editorial Standards

This article has been written in accordance with UK medical editorial best practice, drawing on current immunological understanding of kiwi allergen components as recognised in peer-reviewed allergy science. All content is intended to be educational and informational. It reflects evidence-based knowledge available at the time of writing and is designed to support health literacy, not to replace clinical evaluation.

Our clinic is a nurse-led health screening service. We provide blood testing and results reporting only. We do not offer prescriptions, treatment, diagnosis, or specialist clinical services.

Take a Proactive Step Towards Clarity

Understanding your body's immune responses is a meaningful part of managing your overall wellbeing. If you have been experiencing unexplained reactions to kiwi or related foods, component-resolved allergy blood testing may provide a clearer picture to inform your next healthcare conversation. When you feel ready, our nurse-led team is here to support you with straightforward, professional screening — at a time that suits you.

Find out more about our allergy testing services

Disclaimer

This article is intended for educational and informational purposes only. It does not constitute medical advice, and the content should not be used as a basis for self-diagnosis or self-treatment. Individual symptoms, health concerns, and test results should always be assessed by a qualified and appropriate healthcare professional. Specific IgE blood testing indicates sensitisation and does not confirm clinical allergy. No outcomes, diagnoses, or treatment results are implied or guaranteed. This content has been produced in line with GMC advertising guidance, CQC patient communication standards, and ASA guidelines for health-related communications.

Related reading

What Our Patients Say

Verified Google reviews for our South Kensington clinic.